Vice President of Clinical (m/f/d)

Vice President of Clinical

(m/f/d)

Permanent employment with our customer Basel Land Start date: asap Reference number: 873408/1

Diesen Job teilen oder drucken

Responsibilities

• Take full ownership of European clinical development strategy, including development pathways, trial design optimization and proactive risk management
• Provide end-to-end medical and clinical leadership across the entire lifecycle of European clinical programs, ensuring scientific rigor, quality and compliance
• Lead and manage direct interactions with EMA, Swissmedic and other European regulatory authorities, including oversight of clinical registration dossiers and regulatory submissions
• Build and maintain strong partnerships with investigators, research sites, CROs/CSOs, and external experts across Europe
• Act as a key integrator across functions and regions, resolving complex cross-organizational topics between Europe and global stakeholders
• Monitor and steer timelines, quality and budgets of European clinical projects, adjusting strategies in response to regulatory or market developments
• Build, lead and develop a high-performing European clinical organization

Profile

• MD or PhD in pharmaceutical sciences or a related field; EU or Swiss medical license is a strong advantage
• Solid experience in pharmaceutical companies or CROs, including significant leadership responsibility in European clinical development
• Proven track record of leading innovative drug programs through EMA registration and approval, up to market launch
• Deep expertise in EMA regulatory processes, requirements and guidelines, with the ability to independently lead regulator interactions
• Strong experience operating in complex international matrix organizations
• Excellent leadership, stakeholder management, and decision-making skills
• Fluent English and Chinese (written and spoken) are required

Benefits

• Executive-level impact in shaping a company’s long-term European clinical and regulatory presence
• Direct reporting line to the Swiss Company CEO
• Rare opportunity to build something from the ground up in Europe with strong global backing